In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Andrew H. Lipsky, MD
Associate Professor of Medicine
Columbia University Medical Center
Herbert Irving Comprehensive Care Center
New York, NY
Consulting Fees: AbbVie, AstraZeneca
Catherine C. Coombs, MD
Associate Clinical Professor
University of California, Irvine
Research: AbbVie, Loxo@Lilly
Ownership Interest: Bluebird Bio, CTI Biopharma
Consulting Fees: AbbVie, AstraZeneca, BeiGene, Genentech, Janssen, Loxo@Lilly, MEI Pharma, MingSight Pharmaceuticals, Octapharma, TG Therapeutics
Jacob D. Soumerai, MD
Assistant Professor of Medicine, Harvard Medical
School, Clinical Investigator in Lymphoma and CLL,
Massachusetts General Hospital Cancer Center
Consulting Fees: AbbVie, AstraZeneca, Verastem Oncology
Research: BeiGene, BostonGene, Genentech/Roche, TG Therapeutics
- Cindy Davidson has nothing to disclose.
- Stephen Chavez has nothing to disclose.
- Barry A. Fiedel, PhD, has nothing to disclose.
- Colleen Resnick has nothing to disclose.
- Anna Trentini has nothing to disclose.